Lagioia, R., Scrutinio, D., Mangini, S
Many patients and clinicians wonder: does GLP-1 affect liver enzymes
06 November, 2025 | Abdul Jabbar - MPharm Retatrutide is a new experimental medication being researched as a potential weight loss treatment
Personalized guidance aligns medication, nutrition, and lifestyle factors
Individual patient factorsincluding other medications, existing health conditions, and personal medical historymust be considered when determining the safety and appropriateness of any medication combination
The allegations, which are drawn from interviews with former employees, legal filings in court cases between Empower and former employees, FDA inspection reports and warning letters, and documents from state boards of pharmacy, show a dark side of the exploding market for GLP-1 weight loss shots and other drugs made by compounders